Literature DB >> 9136852

Vertebral compression fractures in pediatric patients with Crohn's disease.

E J Semeao1, V A Stallings, S N Peck, D A Piccoli.   

Abstract

Osteoporosis is known to be a significant complication of Crohn's disease in adult patients. The association of osteoporosis and the development of vertebral compression fractures is well delineated. This case report describes 5 pediatric patients with Crohn's disease in whom vertebral compression fractures associated with a marked reduction in bone density developed. As in adults, the association of osteoporosis and Crohn's disease in pediatric patients is multifactorial, including corticosteroid use, calcium and vitamin D homeostasis, malnutrition, alteration in sex hormones, and site of disease. At the time of diagnosis of the vertebral fractures, the patients' ages ranged from 10.6 to 16.8 years, they had persistent and severe back pain, and 3 of 5 patients had a decrease in height. They were taking 13.7-41.6 mg/day of corticosteroid, and all 5 patients had terminal ileal involvement. Bone mineral density measured by dual-energy x-ray absorptiometry was well below 2SD from the mean in all patients (z-score, -2.31 to -5.11). Because of the high morbidity and mortality associated with fractures that result from low bone mineral density, medical care of all pediatric patients with Crohn's disease should include an evaluation of bone mineral density.

Entities:  

Mesh:

Year:  1997        PMID: 9136852     DOI: 10.1016/s0016-5085(97)70055-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

Review 1.  Bone abnormalities in gastrointestinal and hepatic disease.

Authors:  F A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

3.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 4.  Assessment of bone mass following renal transplantation in children.

Authors:  Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

5.  Risk of diagnosed fractures in children with inflammatory bowel diseases.

Authors:  Michael D Kappelman; Joseph A Galanko; Carol Q Porter; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

6.  Intestinal inflammation without weight loss decreases bone density and growth.

Authors:  Regina Irwin; Sandi Raehtz; Narayanan Parameswaran; Laura R McCabe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

7.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

8.  Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease.

Authors:  Lindsay M Griffin; Meena Thayu; Robert N Baldassano; Mark D DeBoer; Babette S Zemel; Michelle R Denburg; Lee A Denson; Justine Shults; Rita Herskovitz; Jin Long; Mary B Leonard
Journal:  J Clin Endocrinol Metab       Date:  2015-04-28       Impact factor: 5.958

9.  Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice.

Authors:  Laura Harris; Patricia Senagore; Vincent B Young; Laura R McCabe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

10.  Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.

Authors:  Letícia Helena Caldas Lopes; Vera Lucia Sdepanian; Vera Lúcia Szejnfeld; Mauro Batista de Morais; Ulysses Fagundes-Neto
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.